大脑衰老中的微质细胞:最近基础科学和临床研究进展的概述
Haixia Fan1,2,3,4, Minheng Zhang5, Jie Wen1,2,3
1Chongqing Medical University, Chongqing 400042, China.
Journal of biomedical research
|February 25, 2024
概括
大脑衰老涉及微质细胞的变化,影响认知功能和神经退行性疾病,如阿尔茨海默氏症和帕金森氏症. 了解微质细胞提供了对健康大脑衰老的见解.
科学领域:
- 神经科学是一个神经科学.
- 老年学是指老年学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 衰老会导致逐渐的组织退化和死亡率的增加.
- 大脑经历与年龄相关的变化,包括神经元功能障碍和氧化应激,导致认知能力下降.
- 衰老是神经退行性疾病的主要风险因素,历史上重点关注神经元而不是微质细胞.
研究的目的:
- 提供大脑衰老的概述,重点关注微质细胞的作用.
- 总结关于大脑衰老和微质细胞之间的相关性的当前知识.
- 讨论微质衰老及其对大脑衰老和神经退行性疾病的影响.
主要方法:
- 文献综述和近期关于微质在大脑衰老中的研究的综合.
- 在正常衰老和神经退行性疾病中微质参与的分析.
- 讨论在衰老过程中微质功能背后的分子机制.
主要成果:
- 微质平衡越来越被认为是神经系统疾病发病过程中至关重要的.
- 最近的研究强调了微质在正常大脑衰老和阿尔茨海默病,帕金森病,亨廷顿病和ALS等疾病中的重要作用.
- 衰老的微质细胞与与年龄有关的大脑功能障碍有关.
结论:
- 微质细胞在大脑衰老和神经退行方面发挥着关键作用.
- 向微质通路可能为与年龄相关的认知衰退和神经退行性疾病提供治疗策略.
- 对微质分子复杂性的进一步研究对于促进健康的大脑衰老至关重要.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Aging
1.1K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


